A A+ A++

An innovative platform for home healthcare monitoring and diagnosis of chronic kidney disease

Contract number: InnovativeSMEs/4/79/RenaMed/2023

Objective of the project

The aim of the project is to develop a point-of-care device for monitoring patients with chronic kidney disease (CKD) at home and early diagnosis of CKD cases. The device aims to be a user-friendly, minimally invasive, ultra-cost-effective solution that enables seamless doctor-patient interaction via the cloud platform. The system developed as part of the project will consist of a handy device, a capsule containing a multi-parameter screen printing sensor and a mobile application to display the results and connect to the healthcare facility. The solution will improve the quality of life of patients, improve patient-physician communication, facilitate decision-making, enable personalized treatment, and reduce healthcare costs.
The project is implemented by a Polish-Spanish consortium consisting of two companies – Renalyse (CreatSens Health S.L.) and MedApp. As part of the project, MedApp will be responsible for the development of software for the final product, which includes both the creation of a platform for data collection and presentation as well as AI algorithms for predicting and detecting the stage of CKD, as well as atrial fibrillation from ECG signals.


This project has received funding under the EUREKA and European Union Initiative programme: Eurostars-3, Innovative SMEs – Call 4

Project value:

2 858 162,17 PLN

European Funds contribution:

2 286 529,74 PLN